According to Zhitong Finance App News, Guobang Pharmaceutical (605507.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved revenue of 3.142 billion yuan, an increase of 3.84%; net profit attributable to shareholders of listed companies was 341 million yuan, a year-on-year decrease of 25.07%; deducted non-net profit of 321 million yuan, a year-on-year decrease of 26.46%; and basic earnings per share were 0.44 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.